arrow_back Back Filing freshness 10-K Q4 FY2026 SEC EDGAR

download Export Data

Benitec Biopharma Inc.

BNTC

$9.82 ▼ -1.14 (-10.40%) at close

30 Visible periods

22 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Benitec Biopharma Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap —

Dividend Yield —

Revenue Growth None

Op. Margin —

ROIC -6.4% ↘

FCF / Share None

Trailing P/E —

Price / Book 1.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

30-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-12.81M

↓ -45.5% —

FCF / Share Free cash flow per share

$-0.09

↓ -10.1% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	—	—	N/M	N/M	—	—	12.5% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+56%)	-44.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-650%)	—	—	4700.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+58650%)	2400.0% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+29900%)	N/M	—	-96.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1305%)	-98.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1334%)	66.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+733%)	—	—	—	—	—	—
EPS Growth YoY (%)	-23.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	21.2% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	54.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-90.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	85.4% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	87.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	82.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	95.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-925.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1220.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-487.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	92.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-45.5% Weak ↑ Weak Improving Year-over-year change in net income	-77.2% Weak → Weak Stable Year-over-year change in net income	-77.2% Weak ↓ Weak Declining Year-over-year change in net income	-77.2% Weak ↓ Weak Declining Year-over-year change in net income	-86.5% Weak ↓ Weak Declining Year-over-year change in net income	15.0% Good ↑ Good Improving Year-over-year change in net income	15.0% Good ↑ Good Improving Year-over-year change in net income	15.0% Good ↑ Good Improving Year-over-year change in net income	-1.3% Weak ↑ Weak Improving Year-over-year change in net income	-16.9% Weak ↓ Weak Declining Year-over-year change in net income	-16.9% Weak ↓ Weak Declining Year-over-year change in net income	-16.9% Weak ↓ Weak Declining Year-over-year change in net income	8.0% Fair ↑ Fair Improving Year-over-year change in net income	-1.0% Weak ↑ Weak Improving Year-over-year change in net income	-1.0% Weak ↑ Weak Improving Year-over-year change in net income	-1.0% Weak ↑ Weak Improving Year-over-year change in net income	-26.6% Weak ↑ Weak Improving Year-over-year change in net income	-85.6% Weak ↓ Weak Declining Year-over-year change in net income	-85.6% Weak → Weak Stable Year-over-year change in net income	-85.6% Weak ↑ Weak Improving Year-over-year change in net income	-36.4% Weak ↑ Weak Improving Year-over-year change in net income	-137.0% Weak → Weak Stable Year-over-year change in net income	-137.0% Weak Weak Year-over-year change in net income	-137.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	81.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	79.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-469.5% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	24.5% Excellent Excellent Compound annual revenue growth over 3 years	-43.3% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
FCF / Net Income (x)	0.39x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.42x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.37x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.70x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.77x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.88x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.32x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.08x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.68x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Return on Invested Capital (%)	-6.4% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.0% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-20.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-1779.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-72.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-5.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-7.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-9.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-101.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-52.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-47.1% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-25.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-79.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-24.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-7.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-4.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-133%)	-4.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-9.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-164%)	-9.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-160%)	-5.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-135%)	-6.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-144%)	-7.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-10.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-167%)	-51.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-445%)	-38.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-357%)	-26.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-278%)	—	-108.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-820%)	-56.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-478%)	-34.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-332%)	-175.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1272%)	-67.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-547%)	-46.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-410%)	-32.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-20.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-233%)	-24.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-266%)	-18.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-224%)	-35.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-334%)	-28.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-9.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-162%)	-7.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-150%)	-6.8% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-145%)	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Net Debt (USD)	$-179.97M	$-184.76M	$-188.79M	$-94.48M	$-97.74M	$-103.58M	$-78.28M	$-67.84M	$-50.87M	$-14.10M	$-20.37M	$-25.86M	$-2.48M	$-6.55M	$-10.54M	$-16.53M	$-4.06M	$-8.63M	$-12.33M	$-15.73M	$-19.77M	$-11.99M	$-14.01M	$-7.45M	$-9.80M	$-11.40M	$-13.79M	$-16.63M	$-15.72M	$-11.88M

📊 What does each share earn? 6 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Revenue per Share (USD)	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.26	$-0.24	$-0.26	$-0.22	$-0.21	$-0.24	$-0.33	$-0.48	$-0.11	$-1.64	$-2.64	$-2.76	$-2.65	$-0.16	$-0.20	$-0.47	$-36.27	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	$-0.09	$-0.08	$-0.08	—	—	—	$-0.43	—	—	—	$-2.12	—	—	—	$-0.37	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$5.14	$5.34	$5.47	$3.57	$3.71	$3.82	$3.24	$3.59	$4.68	$4.22	$5.97	$8.76	$0.12	$0.17	$0.32	$0.57	$6.00	$0.92	$1.33	$1.89	$2.45	$2.27	$3.22	$6.98	$9.24	—	—	—	$19.37	—
Tangible Book Value per Share (USD)	$5.14	$5.34	$5.47	$3.57	$3.71	$3.82	$3.24	$3.59	$4.68	$4.22	$5.97	$8.76	$0.12	$0.17	$0.32	$0.57	$6.00	$0.92	$1.33	$1.89	$2.45	$2.27	$3.22	$6.98	$9.24	—	—	—	$19.37	—
Basic Weighted Avg Shares (shares)	—	49.39M	45.97M	41.52M	—	38.60M	22.08M	10.64M	—	2.62M	2.58M	2.16M	—	27.98M	27.56M	10.86M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Working Capital (USD)	$176.34M	$182.74M	$186.79M	$93.05M	$96.72M	$96.98M	$75.62M	$63.78M	$46.75M	$10.93M	$15.05M	$21.88M	$-249.00K	$4.24M	$8.49M	$14.07M	$2.29M	$6.93M	$10.19M	$14.77M	$19.24M	$9.96M	$13.60M	$7.04M	$9.67M	—	—	—	$16.11M	—
Total Equity (USD)	$177.01M	$183.33M	$187.36M	$93.60M	$97.30M	$97.57M	$75.94M	$64.18M	$47.25M	$11.50M	$15.47M	$22.31M	$202.00K	$4.71M	$8.99M	$14.61M	$2.88M	$7.52M	$10.84M	$15.47M	$20.01M	$10.93M	$14.62M	$7.74M	$10.24M	$12.34M	$15.25M	$16.97M	$16.59M	$13.84M

📋 What is driving earnings? 4 metrics

Metric	Q4 FY2026 Jun 30, 2026 10-K ↗	Q3 FY2026 Mar 31, 2026 10-Q ↗	Q2 FY2026 Dec 31, 2025 10-Q ↗	Q1 FY2026 Sep 30, 2025 10-Q ↗	Q4 FY2025 Jun 30, 2025 10-K ↗	Q3 FY2025 Mar 31, 2025 10-Q ↗	Q2 FY2025 Dec 31, 2024 10-Q ↗	Q1 FY2025 Sep 30, 2024 10-Q ↗	Q4 FY2024 Jun 30, 2024 10-K ↗	Q3 FY2024 Mar 31, 2024 10-Q ↗	Q2 FY2024 Dec 31, 2023 10-Q ↗	Q1 FY2024 Sep 30, 2023 10-Q ↗	Q4 FY2023 Jun 30, 2023 10-K ↗	Q3 FY2023 Mar 31, 2023 10-Q ↗	Q2 FY2023 Dec 31, 2022 10-Q ↗	Q1 FY2023 Sep 30, 2022 10-Q ↗	Q4 FY2022 Jun 30, 2022 10-K ↗	Q3 FY2022 Mar 31, 2022 10-Q ↗	Q2 FY2022 Dec 31, 2021 10-Q ↗	Q1 FY2022 Sep 30, 2021 10-Q ↗	Q4 FY2021 Jun 30, 2021 10-K ↗	Q3 FY2021 Mar 31, 2021 10-Q ↗	Q2 FY2021 Dec 31, 2020 10-Q ↗	Q1 FY2021 Sep 30, 2020 10-Q ↗	Q4 FY2020 Jun 30, 2020 10-K ↗	Q3 FY2020 Mar 31, 2020 10-Q ↗	Q2 FY2020 Dec 31, 2019 10-Q ↗	Q1 FY2020 Sep 30, 2019 10-Q ↗	Q4 FY2019 Jun 30, 2019 10-K ↗	Q4 FY2018 Jun 30, 2018 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$54.00K	$14.00K	$0.00	—	$48.00K	$25.00K	$0.00	—	$1.00K	$1.00K	$55.00K	$-35.00K	$28.00K	$77.00K	$33.00K	—	—
Depreciation Expense (USD)	$17.00K	$14.00K	$14.00K	$13.00K	$14.00K	$13.00K	$14.00K	$25.00K	$26.00K	$25.00K	$17.00K	$19.00K	$21.00K	$32.00K	$41.00K	$42.00K	$6.00K	$54.00K	$55.00K	$52.00K	$52.00K	$67.00K	$67.00K	$45.00K	$40.00K	$48.00K	$51.00K	$51.00K	—	—
Net Income, GAAP (USD)	$-12.81M	$-8.96M	$-8.96M	$-8.96M	$-8.80M	$-5.06M	$-5.06M	$-5.06M	$-4.72M	$-5.95M	$-5.95M	$-5.95M	$-4.66M	$-5.09M	$-5.09M	$-5.09M	$-5.07M	$-5.04M	$-5.04M	$-5.04M	$-4.00M	$-2.72M	$-2.72M	$-2.72M	$-2.94M	$-1.15M	$-1.15M	$-1.15M	—	—
Operating Cash Flow (USD)	$-4.94M	$-4.45M	$-3.78M	$-3.35M	$-8.21M	—	—	$-4.59M	$-3.29M	—	—	$-4.58M	$-4.09M	—	—	$-4.04M	$-4.86M	—	—	$-4.28M	$-5.16M	—	—	$-2.36M	$-3.15M	$-769.00K	$-3.08M	$-545.00K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 9 years · 30 quarters

Benitec Biopharma Inc.

Analytical Summary

30-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BNTC with peers